New Discoveries on Wnt/β-catenin Signaling Pathway
- PolyADP-ribose polymerase Tankyrase plays a key role in oncogenic Wnt/β-catenin signaling pathway. This study unveils that in addition to facilitating cytosolic β-catenin accumulation, the polymerization of TNKS and TNKS2 sterile alpha motif domains is also essential to drive oncogenic gene transcription. (Molecular Cell, 2016)
- New mechanism of action for axitinib, a clinically approved tyrosine kinase inhibitor for treating renal cell carcinoma, is demonstrated here. Axitinib is shown to directly target and stabilize SHPRH, an E3 ubiquitin ligase. In doing so, axitinib blocks Wnt/β-catenin signaling pathway by increasing nuclear β-catenin ubiquitination and degradation, and ultimately promotes asymmetric cell division in cancer cells. (PNAS, 2016)
- New therapeutic aspects in treating chemoresistant cancer are proposed. Due to the common upregulation of O6-methylguanine-DNA methyltransferase (MGMT) in patients developing chemoresistance, this study demonstrates that successful inhibition of Wnt/β-catenin signaling downregulates expression of MGMT and restores chemosensitivity. (Nature Communications, 2015)
Wnt/β-catenin Signaling Pathway
(Click to see your products of interest) |
Eight Product Categories and 1700+ Products |
|
|
References |
Laura Mariotti et. al. (2016) Molecular Cell, DOI:10.1016/j.molcel.2016.06.019
Malin Wickström, et. al. (2015) Nature Communications. DOI:10.1038/ncomms9904
Yi Qu, et. al. (2016). PNAS. DOI: 10.1073/pnas.1604520113 |
|